OakChart

Abbott Laboratories

ABTHealthcare·Medical Devices·USA·Large·NYSE·Nov 13 • 7:15 AM ET

107.68+0.43 (0.40%)
2026-11-13 13:17 CET
Market cap
$186.49B
Revenue, TTM
48,229.00 USD m
Net income, TTM
4,725.00 USD m
Free cash flow, TTM
6,757.00 USD m
EPS diluted, TTM
2.71
Price / earnings
39.75
Compare

Price

ABT against its 20, 50 and 200-day averages
Terms2050200Miss
Patternshover a marker to name it
RS 20Sales 13,208Price13,20813,27190.00100.00110.00120.0021.0M42.0MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ABTclose 107.6820-day 106.9250-day 103.89200-day 101.55107.6852w low 81.9752-week range, not 6 months

18.4% under the 52-week high of 132.03 on 18 Nov 2025. 52-week low 81.97 on 11 May 2026. Last 15 sessions, 15.3% high to low

Volume 0.00× normal · the line is the 50-bar volume average

Setup. RS line 20
CANSLIM 2 of 6 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); 52-Week High/Low: 0-10% below High; Performance: Year +50%
VCP 4 of 6 — fails: 52-Week High/Low: 0-10% below High; Average True Range: Under 2
Minervini 2 of 4 — fails: 52-Week High/Low: 0-10% below High; Performance: Year +50%
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 3 of 5 — fails: Performance: Year +50%; 52-Week High/Low: 0-10% below High
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 0 of 4 — fails: EPS Growth Qtr Over Qtr: High (>25%); EPS Growth This Year: High (>25%); EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 2 of 4 — fails: Payout Ratio: Low (<20%); P/E: Under 25
Small Cap 2 of 4 — fails: Float: Under 100M; Performance: Year +50%
Accumulation 2 of 4 — fails: Institutional Transactions: Over +10%; Performance: Year Up
Relative Strength 2 of 3 — fails: Performance: Year +100%

Profile

ABT
52-week range, 51% of the way up
81.97132.03

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

IndexS&P 500, RUI
Employees115000
IPOMar 01, 1937
Beta0.54
ATR, 14d2.84
Rel volume0.00
Short float1.11%
Insider own0.68%
Inst own82.85%

Snapshot

6 groups

Valuation

IndexS&P 500, RUI
Market Cap$186.49B
Enterprise Value213.95B
Income4.72B
Sales48.23B
Book / share29.46
Cash / share2.48
Dividend Est.2.60 (2.42%)
Dividend TTM2.52 (2.34%)
Dividend Ex-DateOct 15, 2026
Dividend Gr. 3/5Y7.72% 9.42%
Payout64.54%
Employees115000
IPOMar 01, 1937

Ratios

Price / earnings39.75
Forward price / earnings18.14
Price / earnings / growth2.25
Price / sales3.87
Price / book3.65
Price / cash43.39
Price / free cash flow27.60
Value / cash profit19.85
Value / sales4.44
Quick Ratio1.00
Current Ratio1.45
Debt / equity0.61
Long-term debt / equity0.58
Options and shortYes / Yes

Earnings

Earnings / share2.71
Earnings next year5.93
Earnings next quarter1.64
Earnings this year7.14%
Earnings next year7.56%
Earnings growth, 5 years8.08%
Past earnings growth-1.70% 8.23%
Past sales growth0.51% 5.08%
Earnings vs last year-66.06%
Sales vs last year10.00%
Earnings vs last quarter-42.12%
Sales vs last quarter14.46%
EarningsOct 21 BMO
Surprise0.03% 0.18%

Ownership

Insiders own0.68%
Insider trades-3.33%
Institutions own82.85%
Institution trades-0.95%
Return on assets4.91%
Return on equity9.27%
Return on capital5.87%
Gross Margin52.33%
Operating margin14.23%
Profit Margin9.80%
20-day average0.71%
50-day average3.64%
200-day average6.03%

Technical

Shares out1.73B
Shares floating1.72B
Short / float1.11%
Short ratio2.13
Short interest19.06M
52-week high132.03 -18.4%
52-week low81.97 +31.4%
Volatility2.12% 2.74%
Average range2.84
Strength index52.33
Market sensitivity0.54
Relative volume0.00
Avg Volume8.94M
Volume423

Performance

Perf Week-2.05%
Perf Month2.86%
Perf Quarter-2.44%
Perf Half Y27.47%
Perf YTD-14.06%
Perf Year-16.70%
Perf 3Y12.41%
Perf 5Y-16.17%
Perf 10Y168.25%
Recommendation1.65
Target Price119.46
Prev Close107.25
Price107.68
Change %0.40%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 27, 2026DowngradeArgusBuy → Hold
Oct 07, 2026InitiatedBarclaysOverweight$120+11.4%
Oct 02, 2026UpgradeRothschild & Co RedburnNeutral → Buy$127+17.9%
Aug 13, 2026UpgradeWolfe ResearchPeer Perform → Outperform$130+20.7%
Jul 01, 2026InitiatedRobert W. BairdOutperform$121+12.4%
Apr 22, 2026DowngradeDaiwa SecuritiesOutperform → Neutral$92-14.6%
Oct 10, 2025InitiatedThe Benchmark CompanyBuy$145+34.7%
Jul 18, 2025UpgradeJefferiesHold → Buy$145+34.7%
Jun 16, 2025InitiatedLeerink PartnersMarket Perform$143+32.8%
Oct 08, 2024InitiatedOppenheimerOutperform$130+20.7%

Peers

Mkt cap
TickerCompanyMkt cap
MDTMedtronic Plc129.18B
BSXBoston Scientific Corp64.47B
DXCMDexcom Inc30.39B
EWEdwards Lifesciences Corp60.83B
JNJJohnson & Johnson682.74B
SYKStryker Corp119.92B
DHRDanaher Corp163.13B
BDXBecton Dickinson & Co58.84B
MMEDMiniMed Group Inc5.06B
BAXBaxter International Inc13.32B

Insider trading

latest 14 of 30
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Moreland Mary KEXECUTIVE VICE PRESIDENTNov 05 '26Sale116.003,500406,000100,791Nov 06 05:09 PM
Mary K. MorelandOfficerNov 05 '26Proposed Sale116.003,500406,000Nov 05 04:22 PM
MCCOY JOHN A. JR.VICE PRESIDENT AND CONTROLLERSep 02 '26Sale109.54272,95824,549Sep 03 06:11 PM
John A. McCoy, Jr.OfficerSep 02 '26Proposed Sale109.52272,957Sep 02 05:17 PM
Ford Robert BCHAIRMAN AND CEOAug 25 '26Option Exercise54.02398,83221,545,946705,293Aug 27 05:09 PM
Ford Robert BCHAIRMAN AND CEOAug 25 '26Sale115.85398,83246,204,798306,461Aug 27 05:09 PM
Robert B. FordOfficerAug 25 '26Proposed Sale115.85398,83246,204,386Aug 25 06:05 PM
Morrone Louis H.EXECUTIVE VICE PRESIDENTAug 11 '26Sale109.835,850642,50670,724Aug 13 05:14 PM
Louis H. MorroneOfficerAug 11 '26Proposed Sale109.835,850642,506Aug 11 06:22 PM
Stratton John GDirectorMay 07 '26Buy86.822,000173,64023,319Jun 18 05:08 PM
Robert J. AlpernRetired DirectorMay 15 '26Proposed Sale85.257,587646,791May 15 04:15 PM
STARKS DANIEL JDirectorApr 27 '26Buy92.6510,000926,5376,751,103Apr 28 07:37 PM
Robert J. AlpernRetired DirectorApr 27 '26Proposed Sale92.5529,2112,703,457Apr 27 06:34 PM
Boudreau Philip PEVP AND CFOApr 23 '26Buy91.502,200201,3002,200Apr 27 05:34 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
SCHDSchwab US Dividend Equity ETFAUM: 123.65B
VOOVanguard S&P 500 ETFAUM: 1070.75B
IVViShares Core S&P 500 ETFAUM: 882.14B
SPYSPDR S&P 500 ETF TrustAUM: 805.69B
VTVVanguard Morningstar Value ETFAUM: 198.14B
XLVState Street Health Care Select Sector SPDR ETFAUM: 50.51B
VIGVanguard Dividend Appreciation FTFAUM: 117.98B
IHIiShares U.S. Medical Devices ETFAUM: 4.08B
VYMVanguard High Dividend Yield Indx ETFAUM: 83.97B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 1.420 beat 1.420, from 1.300 a year earlier. Sales 13,013 beat 12,989, from 11,369 a year earlier
EPS
1.50002024Q4 EPS 1.340 against 1.33624Q42025Q1 EPS 1.090 against 1.07225Q12025Q2 EPS 1.260 against 1.25625Q22025Q3 EPS 1.300 against 1.30325Q32025Q4 EPS 1.500 against 1.49625Q42026Q1 EPS 1.150 against 1.14526Q12026Q2 EPS 1.310 against 1.27726Q22026Q3 EPS 1.420 against 1.42026Q3
Sales, USD millions
13,01302024Q4 sales 10,974 against 11,03124Q42025Q1 sales 10,358 against 10,40625Q12025Q2 sales 11,142 against 11,09225Q22025Q3 sales 11,369 against 11,39025Q32025Q4 sales 11,459 against 11,80025Q42026Q1 sales 11,164 against 11,00026Q12026Q2 sales 12,593 against 12,51926Q22026Q3 sales 13,013 against 12,98926Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-10-21 08:301.4201.4200.53013,01312,989EPS +0.0% · sales +0.2%vs 2025Q3, year-ago quarter · EPS +9.2% · sales +14.5%23 EPS · 24 salesOpen -1.11% vs SPY +0.28%. Close -1.89% vs SPY +0.53%
2026Q2ended 2026-06-302026-07-16 08:301.3101.2770.53212,59312,519EPS +2.6% · sales +0.6%vs 2025Q2, year-ago quarter · EPS +4.0% · sales +13.0%23 EPS · 24 salesOpen +6.74% vs SPY -0.27%. Close +10.71% vs SPY -0.54%
2026Q1ended 2026-03-312026-04-16 08:301.1501.1450.61711,16411,000EPS +0.5% · sales +1.5%vs 2025Q1, year-ago quarter · EPS +5.5% · sales +7.8%25Open -4.36% vs SPY +0.16%. Close -6.00% vs SPY +0.25%
2025Q4ended 2025-12-312026-01-22 08:301.5001.4961.03011,45911,800EPS +0.3% · sales -2.9%vs 2024Q4, year-ago quarter · EPS +11.9% · sales +4.4%25Open -10.93% vs SPY +0.65%. Close -10.04% vs SPY +0.52%
2025Q3ended 2025-09-302025-10-15 08:301.3001.3030.91511,36911,390EPS -0.2% · sales -0.2%vs 2024Q3, year-ago quarter · EPS +7.4% · sales +6.9%24 EPS · 25 salesOpen -3.95% vs SPY +0.69%. Close -2.87% vs SPY +0.44%
2025Q2ended 2025-06-302025-07-17 08:301.2601.2561.02811,14211,092EPS +0.3% · sales +0.5%vs 2024Q2, year-ago quarter · EPS +10.5% · sales +7.4%22 EPS · 23 salesOpen -3.94% vs SPY +0.03%. Close -8.52% vs SPY +0.61%
2025Q1ended 2025-03-312025-04-16 08:301.0901.0720.74410,35810,406EPS +1.7% · sales -0.5%vs 2024Q1, year-ago quarter · EPS +11.2% · sales +4.0%21 EPS · 19 salesOpen +2.75% vs SPY -1.10%. Close +2.76% vs SPY -2.22%
2024Q4ended 2024-12-312025-01-22 08:301.3401.3365.28610,97411,031EPS +0.3% · sales -0.5%vs 2023Q4, year-ago quarter · EPS +12.6% · sales +7.2%22 EPS · 20 salesOpen -2.28% vs SPY +0.48%. Close +0.85% vs SPY +0.56%
2024Q3ended 2024-09-302024-10-16 08:301.2101.2020.93810,63510,551EPS +0.6% · sales +0.8%vs 2023Q3, year-ago quarter · EPS +6.1% · sales +4.9%22 EPS · 20 salesOpen +1.69% vs SPY 0.00%. Close +1.53% vs SPY +0.43%
2024Q2ended 2024-06-302024-07-18 08:301.1401.1050.74110,37710,369EPS +3.2% · sales +0.1%vs 2023Q2, year-ago quarter · EPS +5.6% · sales +4.0%21 EPS · 18 salesOpen -2.19% vs SPY +0.28%. Close -4.40% vs SPY -0.77%
2024Q1ended 2024-03-312024-04-17 08:300.9800.9550.6979,9649,883EPS +2.6% · sales +0.8%vs 2023Q1, year-ago quarter · EPS -4.9% · sales +2.2%20 EPS · 17 salesOpen -1.54% vs SPY +0.50%. Close -3.03% vs SPY -0.59%
2023Q4ended 2023-12-312024-01-24 08:301.1901.1900.91210,24110,186EPS +0.0% · sales +0.5%vs 2022Q4, year-ago quarter · EPS +15.5% · sales +1.5%20 EPS · 17 salesOpen -2.85% vs SPY +0.61%. Close -2.83% vs SPY +0.11%
2023Q3ended 2023-09-302023-10-18 08:301.1401.1010.81910,1439,840EPS +3.6% · sales +3.1%vs 2022Q3, year-ago quarter · EPS -0.9% · sales -2.6%20 EPS · 16 sales-
2023Q2ended 2023-06-302023-07-20 08:301.0801.0500.7839,9789,711EPS +2.9% · sales +2.7%vs 2022Q2, year-ago quarter · EPS -24.5% · sales -11.4%20 EPS · 16 sales-
2023Q1ended 2023-03-312023-04-19 08:301.0300.9900.7529,7479,666EPS +4.0% · sales +0.8%vs 2022Q1, year-ago quarter · EPS -40.5% · sales -18.1%21 EPS · 17 sales-
2022Q4ended 2022-12-312023-01-25 08:301.0300.9260.58910,0919,665EPS +11.3% · sales +4.4%vs 2021Q4, year-ago quarter · EPS -22.0% · sales -12.0%20 EPS · 17 sales-

Annual earnings

2025FY EPS 5.150 missed 5.152, from 4.670 a year earlier. Sales 44,328 missed 44,672, from 41,950 a year earlier
EPS
5.34002018FY EPS 2.880 against 2.88320182019FY EPS 3.240 against 3.24320192020FY EPS 3.650 against 3.55120202021FY EPS 5.210 against 5.09920212022FY EPS 5.340 against 5.23220222023FY EPS 4.440 against 4.43920232024FY EPS 4.670 against 4.67520242025FY EPS 5.150 against 5.1522025
Sales, USD millions
44,67202018FY sales 30,578 against 30,66720182019FY sales 31,904 against 31,85920192020FY sales 34,608 against 33,84920202021FY sales 43,075 against 42,31720212022FY sales 43,653 against 43,22420222023FY sales 40,109 against 40,07520232024FY sales 41,950 against 42,00020242025FY sales 44,328 against 44,6722025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2030FYestimate-7.942--65,79813.56
2029FYestimate-7.206--61,43914.94
2028FYestimate-6.501--57,15016.56
2027FYestimate-5.934--53,64418.15
2026FYestimate-5.518--49,98119.52
2025FY5.1505.1523.72044,32844,67224.33
2024FY4.6704.6757.63841,95042,00024.22
2023FY4.4404.4393.26040,10940,07524.79
2022FY5.3405.2323.91443,65343,22420.56
2021FY5.2105.0993.93643,07542,31727.01
2020FY3.6503.5512.50534,60833,84930.00
2019FY3.2403.2432.05831,90431,85926.81
2018FY2.8802.8831.32930,57830,66725.12
2017FY2.5002.4970.26827,39027,19922.83
2016FY2.2002.2040.92920,85320,89417.46
2015FY2.1502.1501.76020,40520,44150.08
2014FY2.2802.2571.49020,24720,37147.23
2013FY2.0102.0141.62021,84821,92753.57
2012FY2.4262.1941.78039,87431,48444.39
2011FY2.2302.2261.44038,85139,02648.29
2010FY1.9951.9951.41635,16735,04353.97

Quarterly results

2026Q3 revenue 13,013, from 11,369 a year earlier. Operating margin 10.5%, from 19.0% a year earlier
Revenue, USD millions
13,01302024Q4 revenue 10,97424Q42025Q1 revenue 10,35825Q12025Q2 revenue 11,14225Q22025Q3 revenue 11,36925Q32025Q4 revenue 11,45925Q42026Q1 revenue 11,16426Q12026Q2 revenue 12,59326Q22026Q3 revenue 13,01326Q3
Operating margin
20.702024Q4 operating margin 18.1%24Q42025Q1 operating margin 16.3%25Q12025Q2 operating margin 18.6%25Q22025Q3 operating margin 19.0%25Q32025Q4 operating margin 20.7%25Q42026Q1 operating margin 12.7%26Q12026Q2 operating margin 13.6%26Q22026Q3 operating margin 10.5%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 5.52 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYSUSD millions2026-11-0549,9810.0%
2026Q4SUSD millions2026-11-0513,208-0.1%
2026FYEper share2026-11-045.52+0.0%
2026Q4Eper share2026-10-301.640.0%
2026FYRper share2026-10-252.78-1.9%
2026Q4Rper share2026-10-221.10-2.2%
2026Q3Eper share2026-10-191.42+0.0%
2026Q3SUSD millions2026-10-1512,989+0.0%
2026Q3Rper share2026-10-090.95-0.1%
2026Q2Eper share2026-07-161.31+2.6%
2026Q2Rper share2026-07-160.53-43.7%
2026Q2SUSD millions2026-07-1612,535+0.1%
2026Q1Eper share2026-04-151.140.0%
2026Q1SUSD millions2026-04-1511,0000.0%
2026Q1Rper share2026-04-130.860.0%
2025FYEper share2026-01-205.150.0%
2025Q4Eper share2026-01-201.500.0%
2025FYSUSD millions2026-01-1944,672+0.0%
2025Q4SUSD millions2026-01-1911,800+0.0%
2025Q4Rper share2026-01-161.22-0.1%
2025FYRper share2026-01-043.970.0%
2025Q3Eper share2025-10-131.300.0%
2025Q3SUSD millions2025-10-1311,393-0.1%
2025Q3Rper share2025-10-101.040.0%
2025Q2Eper share2025-07-141.25+0.0%
2025Q2SUSD millions2025-07-1411,0600.0%
2025Q2Rper share2025-07-011.000.0%
2025Q1Eper share2025-04-141.07+0.0%
2025Q1SUSD millions2025-04-1410,407+0.0%
2025Q1Rper share2025-04-120.78-2.5%
2024FYEper share2025-01-224.670.0%
2024Q4Eper share2025-01-221.330.0%
2024FYRper share2025-01-223.400.0%
2024Q4Rper share2025-01-221.060.0%
2024FYSUSD millions2025-01-2242,0020.0%
2024Q4SUSD millions2025-01-2211,0340.0%
2024Q3Eper share2024-10-141.20+0.0%
2024Q3Rper share2024-10-110.89+0.0%
2024Q3SUSD millions2024-10-1110,5510.0%
2024Q2Eper share2024-07-151.110.0%
2024Q2SUSD millions2024-07-1210,3690.0%
2024Q2Rper share2024-07-100.81+0.4%
2024Q1SUSD millions2024-04-129,8830.0%
2024Q1Eper share2024-04-100.96-0.1%
2024Q1Rper share2024-04-100.660.0%
2023FYEper share2024-01-184.440.0%
2023FYSUSD millions2024-01-1840,0750.0%
2023FYRper share2024-01-163.24+0.0%

Estimate history

Annual
Metric201720182019202020212022202320242025TTMMRQ
EPS per share0.2681.3292.0582.5053.9363.9143.267.6383.7192.7086-
Sales USD millions27,39030,57831,90434,60843,07543,65340,10941,95044,32848,229-
Shares million shares1,7441,7561,7631,7711,7641,7381,7341,7321,737-1,732
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share0.9385.2860.7441.0280.9151.030.6170.5320.529
Sales USD millions10,63510,97410,35811,14211,36911,45911,16412,59313,013
Shares million shares1,7341,7321,7401,7401,7391,7371,7421,7301,732

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Total Revenue48,229.0044,328.00+5.7%41,950.00+4.6%40,109.00-8.1%43,653.00+1.3%43,075.00+24.5%34,608.00+8.5%31,904.00+4.3%30,578.00
Cost of Goods Sold Incl. D&A22,993.0020,955.00+1.6%20,625.00+2.8%20,072.00-5.9%21,330.00+7.4%19,861.00+15.3%17,231.00+13.3%15,211.00+3.1%14,755.00
Gross Profit25,236.0023,373.00+9.6%21,325.00+6.4%20,037.00-10.2%22,323.00-3.8%23,214.00+33.6%17,377.00+4.1%16,693.00+5.5%15,823.00
Selling, General and Administrative Excl. Other18,371.0015,109.00+4.4%14,474.00+6.4%13,602.00-2.6%13,961.00-0.4%14,014.00+16.0%12,086.00-0.1%12,102.00+1.0%11,979.00
Research and Development3,300.002,889.00+2.3%2,823.00+3.8%2,719.00-4.7%2,852.00+4.2%2,738.00+13.2%2,418.00+0.4%2,408.00+5.2%2,288.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income6,865.008,264.00+20.6%6,851.00+6.5%6,435.00-23.0%8,362.00-9.1%9,200.00+73.9%5,291.00+15.2%4,591.00+19.4%3,844.00
Interest Expense750.00525.00-12.9%603.00-13.6%698.00+121.6%315.00-23.2%410.00-42.1%708.00-13.4%818.00+12.2%729.00
Unusual Expense-73.00170.00-2.00-101.1%188.00-10.0%209.00-60.0%523.00+246.4%151.00-24.9%201.00-18.6%247.00
Net Income Before Taxes6,562.008,466.00+20.7%7,013.00+5.2%6,664.00-19.8%8,306.00+1.2%8,211.00+65.3%4,968.00+21.9%4,077.00+41.9%2,873.00
Income Taxes1,861.001,942.00-6,389.00-779.0%941.00-31.5%1,373.00+20.4%1,140.00+129.4%497.00+27.4%390.00-27.6%539.00
Consolidated Net Income4,725.006,500.00-51.3%13,351.00+134.2%5,701.00-17.4%6,905.00-1.9%7,042.00+58.3%4,449.00+21.4%3,666.00+58.1%2,319.00
Net Income From Continuing Operations4,725.006,500.00-51.3%13,351.00+134.2%5,701.00-17.4%6,905.00-1.9%7,042.00+58.3%4,449.00+21.4%3,666.00+58.1%2,319.00
Net Income4,725.006,500.00-51.3%13,351.00+134.2%5,701.00-17.4%6,905.00-1.9%7,042.00+57.4%4,473.00+22.0%3,666.00+55.8%2,353.00
EPS (Recurring) per share2.693.79-50.4%7.64+129.4%3.33-16.8%4.00-3.4%4.14+61.7%2.56+19.6%2.14+49.7%1.43
EPS (Basic, Before Extraordinaries) per share2.723.73-51.4%7.67+133.8%3.28-16.8%3.94-0.8%3.97+57.5%2.52+21.7%2.07+54.5%1.34
EPS (Diluted) per share2.713.72-51.3%7.64+134.4%3.26-16.6%3.91-0.8%3.94+57.6%2.50+21.4%2.06+54.9%1.33
EBITDA10,776.0011,380.00+13.0%10,069.00+4.0%9,678.00-16.8%11,629.00-8.7%12,738.00+47.8%8,618.00+13.3%7,605.00+6.8%7,122.00
Non-Operating Income (Expense)374.00897.00+17.6%763.00-31.6%1,115.00+138.2%468.00-56.00-110.4%536.00+6.1%505.00+10000.0%5.00
Other After Tax Adjustments24.00-24.00-51.00-22.00-28.00-29.00-22.00-21.00-15.00
Stock Option Compensation Expense712.27441.00-10.4%492.00-1.6%500.00-2.9%515.00+38.1%373.00+7.8%346.00+7.5%322.00+10.3%292.00
Price To Earnings Ratio ratio statement ratio, not the snapshot39.6039.6034.4037.4124.7635.6843.6542.1554.38
Price To Sales Ratio ratio3.564.944.714.804.445.855.654.854.19
Gross Margin %52.3352.7350.8349.9651.1453.8950.2152.3251.75
Operating Margin %14.2318.6416.3316.0419.1621.3615.2914.3912.57
Net Margin %9.8014.6631.8314.2115.8216.3512.9211.497.70
Shares Outstanding million shares1,731.941,736.60+0.3%1,731.70-0.1%1,734.08-0.2%1,737.80-1.5%1,764.08-0.4%1,771.23+0.5%1,762.50+0.4%1,755.62
Market Capitalization185,750.57185,750.57-5.3%196,184.77+2.7%191,088.12-0.2%191,426.55-23.1%248,869.13+28.2%194,055.70+26.4%153,516.36+20.8%127,035.35

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue13,013.00+14.5%12,593.00+13.0%11,164.00+7.8%11,459.00+4.4%11,369.00+6.9%11,142.00+7.4%10,358.00+4.0%10,974.00+7.2%
Cost of Goods Sold Incl. D&A6,459.00+18.5%5,964.00+13.3%5,242.00+6.7%5,328.00-0.9%5,451.00+4.6%5,266.00+3.8%4,914.00-0.6%5,376.00+7.9%
Gross Profit6,554.00+10.7%6,629.00+12.8%5,922.00+8.8%6,131.00+9.5%5,918.00+9.1%5,876.00+10.8%5,444.00+8.4%5,598.00+6.5%
Selling, General and Administrative Excl. Other5,186.00+38.1%4,917.00+29.3%4,507.00+20.0%3,761.00+4.2%3,755.00+4.1%3,802.00+5.1%3,756.00+3.3%3,608.00+6.3%
Research and Development920.00+23.0%892.00+24.2%767.00+9.1%721.00-1.0%748.00+4.9%718.00+3.0%703.00+2.9%728.00+5.5%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income1,368.00-36.8%1,712.00-17.5%1,415.00-16.2%2,370.00+19.1%2,163.00+19.0%2,074.00+23.0%1,688.00+21.9%1,990.00+6.8%
Interest Expense183.00+51.2%328.00+143.0%104.00-22.4%135.00-11.2%121.00-27.1%135.00-19.6%134.00+14.5%152.00-35.3%
Unusual Expense-50.00-159.5%-15.00-121.7%-45.0037.00+164.3%84.00-6.7%69.000.0014.00-86.8%
Net Income Before Taxes1,231.00-43.5%1,524.00-29.1%1,449.00-18.5%2,358.00+16.2%2,180.00+12.4%2,150.00+33.8%1,778.00+23.8%2,030.00+13.1%
Income Taxes311.00-42.0%596.00+60.6%372.00-17.9%582.00536.00+82.3%371.00+21.6%453.00+114.7%-7,199.00-3681.6%
Consolidated Net Income920.00-42.5%928.00-48.4%1,077.00-17.2%1,800.00-80.4%1,600.00-2.4%1,800.00+38.8%1,300.00+6.6%9,195.00+479.0%
Net Income From Continuing Operations920.00-42.5%928.00-48.4%1,077.00-17.2%1,800.00-80.4%1,600.00-2.4%1,800.00+38.8%1,300.00+6.6%9,195.00+479.0%
Net Income920.00-42.5%928.00-48.4%1,077.00-17.2%1,800.00-80.4%1,600.00-2.4%1,800.00+38.8%1,300.00+6.6%9,195.00+479.0%
EPS (Recurring) per share0.51-46.3%0.53-50.0%0.60-18.9%1.05-80.1%0.95-2.1%1.06+43.2%0.74+10.4%5.27+454.7%
EPS (Basic, Before Extraordinaries) per share0.53-42.4%0.53-48.5%0.62-17.3%1.04-80.4%0.92-2.1%1.03+39.2%0.75+7.1%5.31+477.2%
EPS (Diluted) per share0.53-41.8%0.53-48.5%0.62-16.2%1.03-80.5%0.91-3.2%1.03+39.2%0.74+5.7%5.29+481.3%
EBITDA2,624.00-11.2%2,772.00-2.8%2,218.00-9.2%3,162.00+13.0%2,954.00+12.8%2,851.00+14.5%2,444.00+11.6%2,797.00+4.5%
Non-Operating Income (Expense)-4.00-101.8%125.00-55.4%93.00-58.5%160.00-22.3%222.00-41.3%280.00+218.2%224.00+140.9%206.00-24.3%
Other After Tax Adjustments0.000.00-100.0%0.0024.00-44.0021.00-25.00-34.00
Stock Option Compensation Expense136.00+43.5%157.00+55.3%330.00+8.9%89.27+2.7%94.80+2.6%101.12+3.2%303.00+19.1%86.90-2.7%
Price To Earnings Ratio ratio statement ratio, not the snapshot39.6025.2827.6215.7216.7517.6417.3134.40
Price To Sales Ratio ratio3.563.403.974.945.345.525.474.71
Gross Margin %50.3752.6453.0553.5052.0552.7452.5651.01
Operating Margin %10.5113.5912.6720.6819.0318.6116.3018.13
Net Margin %7.077.379.6515.7114.0716.1612.5583.79
Shares Outstanding million shares1,731.94-0.4%1,730.38-0.6%1,741.81+0.1%1,736.60+0.3%1,738.87+0.3%1,740.46+0.0%1,739.84+0.0%1,731.70-0.1%
Market Capitalization185,750.57-20.3%158,051.84-33.2%178,407.61-22.5%217,863.02+11.0%233,117.21+17.5%236,635.64+30.9%230,057.55+16.6%196,184.77+2.7%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/20182017FY12/31/2017
Cash & Short Term Investments8,939.00+12.2%7,967.00+9.5%7,279.00-28.4%10,170.00-0.8%10,249.00+43.4%7,148.00+72.7%4,140.00+1.3%4,086.00-57.5%9,610.00
Short Term Receivables7,929.00+14.5%6,925.00+5.5%6,565.00+5.6%6,218.00-4.1%6,487.00+1.1%6,414.00+18.2%5,425.00+4.7%5,182.00-1.3%5,249.00
Inventories6,488.00+4.7%6,194.00-5.7%6,570.00+6.4%6,173.00+19.7%5,157.00+2.9%5,012.00+16.1%4,316.00+13.7%3,796.00+5.4%3,601.00
Other Current Assets2,640.00+2.7%2,570.00+13.9%2,256.00-15.3%2,663.00+13.5%2,346.00+25.7%1,867.00+4.5%1,786.00+13.9%1,568.00-7.1%1,687.00
Total Current Assets25,996.00+9.9%23,656.00+4.3%22,670.00-10.1%25,224.00+4.1%24,239.00+18.6%20,441.00+30.5%15,667.00+7.1%14,632.00-27.4%20,147.00
Net Property, Plant & Equipment12,942.00+10.3%11,733.00+4.1%11,276.00+9.7%10,278.00+1.6%10,112.00-0.2%10,130.00+12.9%8,972.00+18.6%7,563.00-0.6%7,607.00
Total Investments and Advances918.00+3.6%886.00+10.9%799.00+4.3%766.00-15.2%903.00-12.4%1,031.00+10.7%931.00+3.8%897.00+1.6%883.00
Intangible Assets29,561.00-0.7%29,755.00-8.4%32,494.00-2.3%33,253.00-7.6%35,970.00-6.6%38,528.00-4.2%40,220.00-4.7%42,196.00-7.2%45,493.00
Other Assets17,296.00+12.4%15,384.00+157.5%5,975.00+21.5%4,917.00+23.8%3,972.00+64.3%2,418.00+15.3%2,097.00+11.2%1,885.00-11.1%2,120.00
Total Assets86,713.00+6.5%81,414.00+11.2%73,214.00-1.6%74,438.00-1.0%75,196.00+3.6%72,548.00+6.9%67,887.00+1.1%67,173.00-11.9%76,250.00
Short Term Debt Incl. Current Port. of LT Debt3,309.00+88.7%1,754.00+32.4%1,325.00-46.6%2,481.00+148.3%999.00+116.7%461.00-72.6%1,683.00+713.0%207.00-71.0%714.00
Accounts Payable4,240.00+1.1%4,195.00-2.3%4,295.00-6.8%4,607.00+4.5%4,408.00+11.7%3,946.00+21.3%3,252.00+9.3%2,975.00+23.9%2,402.00
Income Tax Payable569.00-4.2%594.00+20.7%492.00+43.4%343.00+12.1%306.00-15.5%362.00+60.2%226.00-25.9%305.00-1.3%309.00
Other Current Liabilities8,378.00+10.0%7,614.00-1.5%7,729.00-4.1%8,058.00+9.0%7,392.00+3.6%7,138.00+25.2%5,702.00+3.2%5,525.00+0.7%5,487.00
Total Current Liabilities16,496.00+16.5%14,157.00+2.3%13,841.00-10.6%15,489.00+18.2%13,105.00+10.1%11,907.00+9.6%10,863.00+20.5%9,012.00+1.1%8,912.00
Long Term Debt10,827.00-19.9%13,521.00-7.1%14,548.00-5.9%15,465.00-15.3%18,252.00-6.1%19,429.00+11.6%17,416.00-10.0%19,359.00-28.9%27,210.00
Provision for Risks Charges2,125.00+13.0%1,880.00-4.3%1,964.00+10.1%1,784.00-34.8%2,738.00-12.2%3,119.00+10.7%2,817.00+38.1%2,040.00-23.0%2,648.00
Deferred Tax Liabilities1,956.00+42.6%1,372.00+12.6%1,218.00-33.8%1,841.00-11.1%2,072.00-3.4%2,146.00+0.9%2,126.00+3.4%2,056.00+2.5%2,006.00
Other Liabilities2,538.00-1.7%2,583.00-8.3%2,816.00-4.7%2,954.00-1.7%3,005.00+2.1%2,944.00-12.5%3,364.00-15.6%3,984.00-9.0%4,376.00
Total Liabilities33,942.00+1.3%33,513.00-2.5%34,387.00-8.4%37,533.00-4.2%39,172.00-0.9%39,545.00+8.1%36,586.00+0.4%36,451.00-19.3%45,152.00
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity52,130.00+9.4%47,664.00+23.5%38,603.00+5.2%36,686.00+2.5%35,802.00+9.2%32,784.00+5.5%31,088.00+1.8%30,524.00-1.2%30,897.00
Total Shareholders Equity52,130.00+9.4%47,664.00+23.5%38,603.00+5.2%36,686.00+2.5%35,802.00+9.2%32,784.00+5.5%31,088.00+1.8%30,524.00-1.2%30,897.00
Accumulated Minority Interest641.00+170.5%237.00+5.8%224.00+2.3%219.00-1.4%222.00+1.4%219.00+2.8%213.00+7.6%198.00-1.5%201.00
Total Equity52,771.00+10.2%47,901.00+23.4%38,827.00+5.2%36,905.00+2.4%36,024.00+9.2%33,003.00+5.4%31,301.00+1.9%30,722.00-1.2%31,098.00
Total Liabilities & Stockholders Equity86,713.00+6.5%81,414.00+11.2%73,214.00-1.6%74,438.00-1.0%75,196.00+3.6%72,548.00+6.9%67,887.00+1.1%67,173.00-11.9%76,250.00
Book Value Per Share per share30.02+9.1%27.52+23.6%22.26+5.4%21.11+4.0%20.29+9.6%18.51+4.9%17.64+1.4%17.39-1.9%17.72
Tangible Book Value Per Share per share13.00+25.7%10.34+193.8%3.52+77.8%1.98-0.10-3.24-5.18-6.65-8.37
Full-Time Employees people115,000+0.9%114,0000.0%114,000-0.9%115,000+1.8%113,000+3.7%109,000+1.9%107,000+3.9%103,000+4.0%99,000
Price to Book Ratio ratio3.644.935.105.376.935.924.924.163.10
Return on Assets %7.7317.277.729.239.536.345.433.230.52
Return on Equity %13.0330.9515.1419.0520.5313.9311.907.551.34
Return on Invested Capital %10.3221.8210.7313.2413.038.577.564.720.81
Quick Ratio ratio1.181.231.161.231.461.301.041.201.86
Current Ratio ratio1.581.671.641.631.851.721.441.622.26

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/20192018FY12/31/2018
Net Income4,701.006,524.00-51.3%13,402.00+134.2%5,723.00-17.5%6,933.00-2.0%7,071.00+57.3%4,495.00+21.9%3,687.00+55.7%2,368.00
Depreciation3,911.003,116.00-3.2%3,218.00-0.8%3,243.00-0.7%3,267.00-7.7%3,538.00+6.3%3,327.00+10.4%3,014.00-8.1%3,278.00
Other Funds (Non Cash)800.00729.00-36.9%1,155.00+50.0%770.00-14.4%900.00+29.5%695.00-28.4%971.00+26.8%766.00-4.5%802.00
Funds from Operations9,412.0010,369.00-41.7%17,775.00+82.6%9,736.00-12.3%11,100.00-1.8%11,304.00+28.6%8,793.00+17.8%7,467.00+15.8%6,448.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-557.00-803.00-9,217.00-2,475.00-1,519.00-771.00-892.00-1,331.00-148.00
Income Taxes Payable--5.00-8,028.00-585.00-383.00-908.00-614.00-545.00-214.00
Cash from Operating Activities8,855.009,566.00+11.8%8,558.00+17.9%7,261.00-24.2%9,581.00-9.0%10,533.00+33.3%7,901.00+28.8%6,136.00-2.6%6,300.00
Capital Expenditures-2,098.00-2,171.00-2,207.00-2,202.00-1,777.00-1,885.00-2,177.00-1,638.00-1,394.00
Net Assets From Acquisitions-20,103.00-105.000.00-877.000.00-187.00-42.00-170.000.00
Sale of Fixed Assets and Businesses0.000.00-100.0%1.00-97.5%40.00-16.7%48.00-64.2%134.00+131.0%58.00+20.8%48.000.0%48.00
Purchase or Sale of Investments-167.00-164.00-141.00-116.00-33.00-96.00-73.00-82.00-58.00
Purchase of Investments-167.00-167.00-169.00-159.00-185.00-173.00-83.00-103.00-131.00
Sale Or Maturity of Investments-3.00-89.3%28.00-34.9%43.00-71.7%152.00+97.4%77.00+670.0%10.00-52.4%21.00-71.2%73.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources55.0018.00+100.0%9.00-59.1%22.000.0%22.00-15.4%26.00+36.8%19.00-29.6%27.00-43.8%48.00
Cash from Investing Activities-22,295.00-2,422.00-2,338.00-3,133.00-1,740.00-2,008.00-2,215.00-1,815.00-1,356.00
Cash Dividends Paid-4,324.00-4,116.00-3,836.00-3,556.00-3,309.00-3,202.00-2,560.00-2,270.00-1,974.00
Change in Capital Stock-1,314.00-497.00-1,031.00-1,060.00-3,628.00-2,044.00-158.00-420.00-1372.7%33.00
Repurchase of Common Pref Stock-1,538.00-893.00-1,295.00-1,227.00-3,795.00-2,299.00-403.00-718.00-238.00
Sale of Common Pref Stock224.00396.00+50.0%264.00+58.1%167.000.0%167.00-34.5%255.00+4.1%245.00-17.8%298.00+10.0%271.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net15,631.00-1,614.00-537.00-2,475.00-699.00-248.00-50.00-1,599.00-8,450.00
Change in Long Term Debt15,676.00-1,499.00-437.00-2,496.00-746.00-44.00-52.00-1,599.00-8,424.00
Issuance of Long Term Debt19,831.005.00-97.8%223.00+11050.0%2.00-71.4%7.00+75.0%4.00-99.7%1,281.00-30.5%1,842.00-54.1%4,009.00
Reduction of Long Term Debt-4,155.00-1,504.00-660.00-2,498.00-753.00-48.00-1,333.00-3,441.00-12,433.00
Net Financing Active Other Cash Flow0.00-82.000.000.000.000.00-11.000.000.00
Other Financing Activities Uses0.00-82.000.000.000.000.00-11.000.000.00
Cash from Financing Activities9,993.00-6,309.00-5,404.00-7,091.00-7,636.00-5,494.00-2,779.00-4,289.00-10,391.00
Exchange Rate Effect-12.0071.00-96.00-23.00-122.00-70.00-198.6%71.00-16.00-116.00
Net Change in Cash-3,459.00906.00+25.8%720.00-2,986.00-3697.6%83.00-97.2%2,961.00-0.6%2,978.00+18512.5%16.00-5,563.00
Free Cash Flow6,757.007,395.00+16.4%6,351.00+25.5%5,059.00-35.2%7,804.00-9.8%8,648.00+51.1%5,724.00+27.3%4,498.00-8.3%4,906.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow ratio70.5966.7978.61128.0943.0946.2361.8069.4343.66
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments4,298.00-44.4%5,603.00-23.1%7,295.00+6.6%8,939.00+12.2%7,733.00-0.7%7,282.00+0.9%6,844.00+2.9%7,967.00+9.5%
Short Term Receivables9,032.00+11.0%8,599.00+7.9%8,210.00+12.1%7,929.00+14.5%8,138.00+15.4%7,972.00+16.3%7,327.00+10.9%6,925.00+5.5%
Inventories7,337.00+9.4%7,315.00+5.2%6,989.00+5.3%6,488.00+4.7%6,708.00-1.5%6,954.00+2.1%6,639.00-2.8%6,194.00-5.7%
Other Current Assets2,829.00+25.2%3,000.00+32.7%3,014.00+28.6%2,640.00+2.7%2,260.00+5.1%2,260.00+1.3%2,343.00+2.2%2,570.00+13.9%
Total Current Assets23,496.00-5.4%24,517.00+0.2%25,508.00+10.2%25,996.00+9.9%24,839.00+4.4%24,468.00+5.8%23,153.00+3.5%23,656.00+4.3%
Net Property, Plant & Equipment12,880.00+12.0%12,812.00+12.4%12,377.00+13.2%12,942.00+10.3%11,504.00+8.3%11,395.00+11.4%10,932.00+8.2%11,733.00+4.1%
Total Investments and Advances1,099.00+15.6%1,111.00+16.0%1,090.00+20.2%918.00+3.6%951.00+4.3%958.00+9.2%907.00+10.9%886.00+10.9%
Intangible Assets52,234.00+76.7%52,455.00+75.6%53,096.00+79.3%29,561.00-0.7%29,569.00-4.6%29,872.00-4.1%29,620.00-6.5%29,755.00-8.4%
Other Assets18,538.00+7.0%18,320.00+5.9%18,358.00+9.0%17,296.00+12.4%17,318.00+116.2%17,306.00+126.1%16,836.00+124.9%15,384.00+157.5%
Total Assets108,247.00+28.6%109,215.00+30.0%110,429.00+35.6%86,713.00+6.5%84,181.00+13.2%83,999.00+15.0%81,448.00+12.4%81,414.00+11.2%
Short Term Debt Incl. Current Port. of LT Debt1,708.00+27.0%3,005.00+492.7%4,409.00+771.3%3,309.00+88.7%1,345.00-37.6%507.00-68.6%506.00-74.8%1,754.00+32.4%
Accounts Payable4,656.00+12.9%4,794.00+11.3%4,679.00+11.0%4,240.00+1.1%4,123.00+2.2%4,306.00+4.4%4,214.00+0.9%4,195.00-2.3%
Income Tax Payable215.00-54.2%411.00+5.4%598.00+23.3%569.00-4.2%469.00-34.2%390.00-35.1%485.00-13.7%594.00+20.7%
Other Current Liabilities9,573.00+10.7%9,604.00+16.6%8,691.00+11.4%8,378.00+10.0%8,645.00+8.0%8,236.00+11.0%7,799.00+7.3%7,614.00-1.5%
Total Current Liabilities16,152.00+10.8%17,814.00+32.6%18,377.00+41.3%16,496.00+16.5%14,582.00-2.1%13,439.00-2.3%13,004.00-7.3%14,157.00+2.3%
Long Term Debt29,451.00+154.0%29,603.00+128.9%29,638.00+132.7%10,827.00-19.9%11,596.00-9.6%12,930.00-1.6%12,736.00+1.3%13,521.00-7.1%
Provision for Risks Charges0.000.000.002,125.00+13.0%0.000.000.001,880.00-4.3%
Deferred Tax Liabilities---1,956.00+42.6%---1,372.00+12.6%
Other Liabilities11,021.00+63.5%10,036.00+47.6%9,713.00+46.2%2,538.00-1.7%6,739.00+2.1%6,801.00+3.7%6,644.00-2.7%2,583.00-8.3%
Total Liabilities56,624.00+72.0%57,453.00+73.2%57,728.00+78.3%33,942.00+1.3%32,917.00-4.1%33,170.00-0.9%32,384.00-3.1%33,513.00-2.5%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity51,027.00+0.1%51,110.00+1.1%52,061.00+6.7%52,130.00+9.4%50,954.00+28.0%50,565.00+28.6%48,811.00+25.8%47,664.00+23.5%
Total Shareholders Equity51,027.00+0.1%51,110.00+1.1%52,061.00+6.7%52,130.00+9.4%50,954.00+28.0%50,565.00+28.6%48,811.00+25.8%47,664.00+23.5%
Accumulated Minority Interest596.00+92.3%652.00+147.0%640.00+153.0%641.00+170.5%310.00+33.6%264.00+9.1%253.00+8.6%237.00+5.8%
Total Equity51,623.00+0.7%51,762.00+1.8%52,701.00+7.4%52,771.00+10.2%51,264.00+28.1%50,829.00+28.5%49,064.00+25.7%47,901.00+23.4%
Total Liabilities & Stockholders Equity108,247.00+28.6%109,215.00+30.0%110,429.00+35.6%86,713.00+6.5%84,181.00+13.2%83,999.00+15.0%81,448.00+12.4%81,414.00+11.2%
Book Value Per Share per share29.46+0.5%29.54+1.7%29.89+6.6%30.02+9.1%29.30+27.7%29.05+28.5%28.05+25.7%27.52+23.6%
Tangible Book Value Per Share per share-0.70-105.7%-0.78-106.6%-0.59-105.3%13.00+25.7%12.30+142.6%11.89+153.0%11.03+169.0%10.34+193.8%
Full-Time Employees people---115,000+0.9%---114,0000.0%
Price to Book Ratio ratio3.643.043.424.284.614.854.824.93
Return on Assets %4.915.596.547.7317.5317.7517.4517.27
Return on Equity %9.2710.6312.4513.0330.6231.0130.6630.96
Return on Invested Capital %1.141.151.322.862.562.832.1115.03
Quick Ratio ratio1.000.971.011.181.241.301.271.23
Current Ratio ratio1.451.381.391.581.701.821.781.67

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income920.00-44.0%928.00-47.8%1,077.00-18.7%1,776.00-80.8%1,644.00-0.1%1,779.00+36.6%1,325.00+8.2%9,229.00+479.0%
Depreciation1,256.00+58.8%1,060.00+36.4%803.00+6.2%792.00-1.9%791.00-1.2%777.00-3.5%756.00-6.1%807.00-0.7%
Other Funds (Non Cash)137.00+14.2%168.00+18.3%317.00+9.7%178.00-70.0%120.00+2.6%142.00+0.7%289.00-4.9%593.00+147.1%
Funds from Operations2,313.00-9.5%2,156.00-20.1%2,197.00-7.3%2,746.00-74.2%2,555.00-0.4%2,698.00+20.0%2,370.00+1.5%10,629.00+301.5%
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-576.00-348.3%332.00-882.00569.00232.00+64.5%-651.00-953.00-7,761.00-2084.9%
Cash from Operating Activities1,737.00-37.7%2,488.00+21.5%1,315.00-7.2%3,315.00+15.6%2,787.00+3.0%2,047.00+4.4%1,417.00+38.2%2,868.00-5.6%
Capital Expenditures-513.00-497.00-399.00-689.00-496.00-502.00-484.00-720.00
Net Assets From Acquisitions-121.00-164.00-19,798.00-20.00-55.00-30.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00-100.0%0.000.00
Purchase or Sale of Investments187.00+107.8%-26.00-161.00-2112.5%-210.0090.00-52.00-167.5%8.00-150.00
Purchase of Investments187.00+325.0%-26.00-161.00-167.0044.00-44.00-257.1%0.00-169.00
Sale Or Maturity of Investments----43.00-326.3%46.00-8.00-116.3%8.0019.00-55.8%
Other Uses0.000.000.000.000.000.000.000.00
Other Sources1.00-75.0%14.00+600.0%34.00+466.7%6.00+50.0%4.00+100.0%2.000.0%6.00+500.0%4.00+100.0%
Cash from Investing Activities-385.00-673.00-20,324.00-913.00-457.00-582.00-470.00-866.00
Cash Dividends Paid-1,094.00-1,102.00-1,098.00-1,030.00-1,031.00-1,029.00-1,026.00-958.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock89.00-1,042.00-3693.1%-64.00-1014.3%-297.00-236.0029.00+190.0%7.00-290.00
Repurchase of Common Pref Stock-11.00-1,045.00-180.00-302.00-305.00-6.00-280.00-315.00
Sale of Common Pref Stock100.00+44.9%3.00-91.4%116.00-59.6%5.00-80.0%69.00-25.0%35.00+169.2%287.00+114.2%25.00-26.5%
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-1,400.00-1,374.0018,475.00-70.00-493.00-1246.5%-15.00-109.4%-1,036.00-613.00
Change in Long Term Debt-1,331.00-1,438.00-143900.0%18,444.001.00-501.001.00-99.5%-1,000.00-639.00
Issuance of Long Term Debt2.00-33.00-1750.0%19,860.00+1985900.0%2.00+100.0%0.00-100.0%2.00-99.1%1.001.000.0%
Reduction of Long Term Debt-1,333.00-1,405.00-1,416.00-1.00-501.00-1.00-1,001.00-640.00
Net Financing Active Other Cash Flow0.000.000.000.000.00-82.000.000.00
Other Financing Activities Uses0.000.000.000.000.00-82.000.000.00
Cash from Financing Activities-2,405.00-3,518.0017,313.00-1,397.00-1,760.00-1,097.00-2,055.00-1,861.00
Exchange Rate Effect1.004.00-92.2%-23.00-195.8%6.00-10.00-127.8%51.0024.00-83.00-432.0%
Net Change in Cash-1,052.00-287.9%-1,699.00-505.5%-1,719.001,011.00+1643.1%560.00-1.9%419.00-40.4%-1,084.0058.00-69.0%
Free Cash Flow1,224.00-46.6%1,991.00+28.9%916.00-1.8%2,626.00+22.3%2,291.00+6.6%1,545.00+8.3%933.00+48.8%2,148.00-5.9%
Price to Free Cash Flow ratio70.5944.3956.2366.7581.5684.9984.2278.52

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Region
Name20242025vs 20242025 share
China2,113.001,907.00-9.7%4.3%
Consolidation, Policy-1.00---
Germany2,539.002,759.00+8.7%6.2%
India1,817.001,871.00+3.0%4.2%
Japan1,441.001,475.00+2.4%3.3%
Other countries14,786.0015,979.00+8.1%36.0%
Switzerland1,747.001,871.00+7.1%4.2%
United Kingdom1,185.001,340.00+13.1%3.0%
United States16,323.0017,126.00+4.9%38.6%
Total41,950.0044,328.00+5.7%100.0%
Segment
Name20242025vs 20242025 share
Consolidation, Policy16.0017.00+6.3%0.0%
Diagnostic Products9,341.008,937.00-4.3%20.2%
Established Pharmaceutical Products5,194.005,536.00+6.6%12.5%
Medical Devices18,986.0021,387.00+12.6%48.2%
Nutritional Products8,413.008,451.00+0.5%19.1%
Total41,950.0044,328.00+5.7%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-301.11%19.1M1720.1M8.76M
2026-10-151.01%17.4M1718.5M9.44M
2026-09-300.79%13.6M1718.5M9.72M
2026-09-151.16%19.9M1718.4M10.76M
2026-08-311.29%22.1M1718.4M11.51M
2026-08-141.19%20.4M1718.4M12.08M
2026-07-311.32%22.6M1718.6M13.12M
2026-07-151.44%24.8M1730.0M13.36M
2026-06-301.35%23.4M1730.0M13.03M
2026-06-151.27%22.0M1728.4M13.03M
2026-05-291.27%22.0M1730.0M12.47M
2026-05-151.34%23.2M1730.0M12.03M
2026-04-301.30%22.5M1729.9M11.63M
2026-04-151.26%21.7M1729.9M12.04M
2026-03-311.38%23.8M1729.9M11.44M
2026-03-131.16%20.0M1725.9M9.61M
2026-02-271.06%18.2M1725.9M8.95M
2026-02-131.00%17.2M1725.9M9.02M
2026-01-301.08%18.7M1727.0M8.04M
2026-01-151.15%19.9M1727.2M6.13M

Option chain

expiry 2026-11-13
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call70.0036.5037.6038.70513.2%45.0040.000.993-0.2400.001
call75.0031.7032.5032.10405.5%45.0075.000.991-0.2340.001
call80.0026.8027.6027.20374.2%1.0035.000.990-0.2280.001
call85.0021.5024.000.00475.5%0.000.000.988-0.2190.002
call87.0019.5022.000.00444.4%0.000.000.987-0.2160.002
call88.0018.6021.100.00436.2%0.000.000.986-0.2140.002
call89.0017.8020.1019.58419.3%0.0012.000.967-0.4960.004
call90.0016.5019.1018.61402.4%0.0012.000.965-0.4900.004
call91.0015.6018.1016.85385.5%1.001.000.964-0.4830.004
call92.0014.6017.1015.85368.7%1.001.000.962-0.4760.004
call93.0013.6016.1010.55351.9%4.000.000.960-0.4680.004
call94.0012.8015.0015.96327.7%7.000.000.957-0.4600.005
call95.0011.8014.1015.03318.3%14.000.000.955-0.4520.005
call96.0010.7013.108.99301.4%1.000.000.952-0.4420.005
call97.009.7012.0013.00277.6%13.000.000.944-0.4700.006
call98.008.8011.1010.20267.3%8.000.000.930-0.5450.007
call99.007.6010.108.05248.6%9.000.000.914-0.6130.008
call1006.808.606.10200.8%70.000.000.903-0.6150.009
call1015.707.6013.04182.7%75.000.000.884-0.6490.010
call1024.606.605.85165.9%82.001.000.861-0.6810.011
call1033.706.107.10178.7%20.000.000.809-0.8360.014
call1042.453.503.2062.4%19.001.000.875-0.3620.011
call1051.753.805.05107.3%20.000.000.733-0.7570.017
call1061.151.952.2759.1%36.001.000.661-0.7130.019
call1070.700.950.7940.0%23732.000.548-0.5530.020
call1080.250.900.3960.3%42.0027.000.402-0.6650.020
call1090.150.250.2544.3%90.0023.000.258-0.5000.017
call1100.000.100.1041.1%2051230.155-0.3780.012
call1110.000.050.0544.1%2511680.105-0.3160.009
call1120.000.100.0552.8%2799.000.086-0.3150.008
call1130.000.100.1061.7%1259.000.077-0.3380.007
call1140.002.150.0570.1%2040.000.065-0.3280.007
call1150.000.650.0378.2%1843.000.048-0.2660.005
call1160.002.150.0585.6%1890.000.045-0.2730.005
call1170.002.150.0384.8%28.000.000.040-0.2300.005
call1180.000.050.0780.8%3650.000.032-0.1650.004
call1190.002.151.10108.9%8.000.000.024-0.1910.003
call1200.002.150.11105.4%7710.000.023-0.1690.003
call1210.000.050.05-3.000.00---
call1220.000.050.03-2.000.00---
call1230.002.150.00117.6%0.000.000.020-0.1600.003
call1240.002.150.00123.7%0.000.000.020-0.1630.003
call1250.002.150.15137.4%21.000.000.019-0.1800.003
call1260.002.150.00135.7%0.000.000.018-0.1670.003
call1270.002.150.00141.5%0.000.000.017-0.1680.002
call1280.002.150.00155.1%0.000.000.017-0.1860.002
call1290.002.150.00157.9%0.000.000.016-0.1830.002
call1300.002.150.00158.6%0.000.000.016-0.1730.002
put70.000.000.050.01338.0%10.000.00-0.007-0.1840.001
put75.000.002.150.00324.8%0.000.00-0.009-0.2330.001
put80.000.002.150.20270.6%4.000.00-0.010-0.2230.001
put85.000.002.150.25214.6%26.000.00-0.012-0.2020.002
put87.000.002.150.11194.6%2.000.00-0.013-0.1960.002
put88.000.002.150.16192.5%2.000.00-0.014-0.2110.002
put89.000.002.150.36189.3%8.000.00-0.024-0.2950.003
put90.000.002.150.41206.7%6.000.00-0.034-0.4820.004
put91.000.002.150.05170.8%29.000.00-0.026-0.2880.003
put92.000.002.150.60185.5%22.000.00-0.038-0.4700.004
put93.000.002.000.10155.9%19.000.00-0.029-0.2880.004
put94.000.002.150.23164.3%12.000.00-0.042-0.4570.005
put95.000.002.150.08153.5%7.000.00-0.045-0.4480.005
put96.000.002.150.20142.7%8.000.00-0.048-0.4380.005
put97.000.002.150.05131.9%68.000.00-0.055-0.4630.006
put98.000.002.150.75121.1%15.000.00-0.070-0.5370.007
put99.000.002.150.06110.2%26.000.00-0.086-0.6080.008
put1000.002.150.3699.0%39.000.00-0.097-0.6110.009
put1010.002.150.1088.2%23.000.00-0.116-0.6450.010
put1020.002.150.8476.7%11.000.00-0.141-0.6860.011
put1030.002.150.0565.6%47.000.00-0.189-0.8230.014
put1040.000.150.0853.9%27.0021.00-0.120-0.3450.010
put1050.050.300.1352.9%14220.00-0.270-0.7600.017
put1060.200.800.3365.7%10611.00-0.343-0.7130.019
put1070.400.900.7050.1%160263-0.452-0.5480.020
put1081.001.451.2551.4%192116-0.593-0.6630.020
put1091.302.251.4758.3%32.005.00-0.742-0.4950.017
put1102.203.202.5668.9%1,4301,107-0.845-0.3730.012
put1113.104.201.8782.5%6.000.00-0.895-0.3110.009
put1123.505.203.6797.0%36179.00-0.914-0.3100.008
put1133.906.403.47122.4%9.000.00-0.923-0.3330.007
put1144.907.504.70142.1%31.0047.00-0.934-0.3220.007
put1155.908.306.60138.8%0.006.00-0.952-0.2610.005
put1166.909.706.17180.9%0.000.00-0.956-0.2660.005
put1177.9010.900.00208.7%0.000.00-0.965-0.2310.004
put1188.9011.503.02190.8%0.000.00-0.974-0.1810.003
put1199.9012.600.00209.9%0.000.00-0.976-0.1840.003
put12010.9013.500.00212.5%0.000.00-0.977-0.1880.003
put12111.9014.800.00247.5%0.000.00-0.978-0.1910.003
put12212.9015.600.00242.0%0.000.00-0.979-0.1940.003
put12313.9016.500.00243.2%0.000.00-0.980-0.1960.002
put12414.9017.600.00262.2%0.000.00-0.981-0.1990.002
put12515.9018.500.00260.3%0.000.00-0.982-0.2010.002
put12616.9019.500.00269.7%0.000.00-0.982-0.2030.002
put12717.9020.700.00300.4%0.000.00-0.983-0.2050.002
put12818.9021.600.00298.0%0.000.00-0.984-0.2070.002
put12919.9022.5020.30297.0%0.002.00-0.984-0.2090.002
put13020.9023.5021.29305.8%0.002.00-0.985-0.2110.002

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-064Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-218-KCurrent report2026-10-21SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-254Statement of changes in beneficial ownership of securities2026-09-23SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-274Statement of changes in beneficial ownership of securities2026-08-25SEC
2026-08-25144Filing for proposed sale of securities under Rule 144.SEC
2026-08-208-KCurrent report2026-08-20SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-11144Filing for proposed sale of securities under Rule 144.SEC
2026-07-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-168-KCurrent report2026-07-16SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-014Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-06-294Statement of changes in beneficial ownership of securities2026-06-27SEC
2026-06-184Statement of changes in beneficial ownership of securities2026-05-07SEC
2026-06-1811-KAnnual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-1100406.00K1
2026-100000
2026-09002.96K1
2026-080046.85M2
2026-070000
2026-060000
2026-05173.64K100
2026-041.13M200
2026-0300485.32K6
2026-021.09M100
2026-012.01M100
2025-120000
2025-1100203.04K1

Institutional holders

Manager% owned
BlackRock, Inc.8.76%
VANGUARD CAPITAL MANAGEMENT LLC6.53%
STATE STREET CORP4.71%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC3.43%
VANGUARD PORTFOLIO MANAGEMENT LLC2.81%
Capital Research Global Investors2.60%
GEODE CAPITAL MANAGEMENT, LLC2.29%
Capital International Investors2.05%
JPMORGAN CHASE & CO1.72%
MORGAN STANLEY1.53%

Funds

Fund% owned
VANGUARD SHORT-TERM INVESTMENT-GRADE FUND22.03%
VANGUARD INTERMEDIATE-TERM INVESTMENT-GRADE FUND7.32%
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND6.93%
Bond Fund4.05%
VANGUARD ULTRA-SHORT-TERM BOND FUND3.18%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.17%
VANGUARD WELLINGTON FUND2.94%
Schwab U.S. Dividend Equity ETF2.75%
VANGUARD 500 INDEX FUND2.59%
DFA Investment Grade Portfolio2.31%

OakChart. ABT. Cached 15 minutes. Terms